Compounds > (3S-5S-6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3-5-dihydroxyhept-6-enoic-acid

(3S-5S-6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3-5-dihydroxyhept-6-enoic-acid and Respiratory-Insufficiency

(3S-5S-6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3-5-dihydroxyhept-6-enoic-acid has been researched along with Respiratory-Insufficiency* in 1 studies

Other Studies

1 other study(ies) available for (3S-5S-6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3-5-dihydroxyhept-6-enoic-acid and Respiratory-Insufficiency

ArticleYear
Relapse of respiratory insufficiency one year after organising pneumonia.
    The European respiratory journal, 2004, Volume: 24, Issue:6

    Topics: Aged; Anticholesteremic Agents; Biopsy; Cryptogenic Organizing Pneumonia; Diagnosis, Differential; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Indoles; Recurrence; Respiratory Insufficiency; Tomography, X-Ray Computed

2004